The Enigmatic Autoimmune Response in Endemic Pemphigus Foliaceus

Actas Dermo-Sifiliograficas

Volumn 100, Issue SUPPL. 2, 2009, Pages 40-48

  Flores, G ^a   Qian, Y ^a   Diaz L A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

desmoglein; ELISA; fogo selvagem; pemphigus foliaceus; pemphigus vulgaris

Indexed keywords

AUTOANTIBODY; DERMOGLEIN 1 ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M; UNCLASSIFIED DRUG;

ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL FEATURE; HUMAN; IMMUNE RESPONSE; INCUBATION TIME; PEMPHIGUS FOLIACEUS;

AUTOIMMUNITY; HUMANS; IMMUNOGLOBULIN G; PEMPHIGUS;

EID: 76749107073     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/S0001-7310(09)73377-0     Document Type: Article

References (96)

1. Bystryn J.C., and Rudolph J.L. Pemphigus. Lancet 366 (2005) 61-73
2. Udey M.C., and Stanley J.R. Pemphigus-diseases of antidesmosomal autoimmunity. JAMA 282 (1999) 572-576
3. Anhalt G.J., Labib R.S., Voorhees J.J., Beals T.F., and Diaz L.A. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med 306 (1982) 1189-1196
4. Roscoe J., Diaz L., Sampaio S., Castro R., Labib R., Takahashi Y., et al. Brazilian pemphigus foliaceus autoantibodies are pathogenic to BALB/c mice by passive transfer. J Invest Dermatol 85 (1985) 538-541
5. Diaz L.A., Sampaio S.A., Rivitti E.A., Martins C.R., Cunha P.R., Lombardi C., et al. Endemic pemphigus foliaceus (Fogo Selvagem): II. Current and historic epidemiologic studies. J Invest Dermatol 92 (1989) 4-12
6. Abreu-Velez A.M., Hashimoto T., Bollag W.B., Tobon Arroyave S., Abreu-Velez C.E., Londono M.L., et al. A unique form of endemic pemphigus in northern Colombia. J Am Acad Dermatol 49 (2003) 599-608
7. Robledo M.A., Prada S., Jaramillo D., and León W. South American pemphigus foliaceus: study of an epidemic in El Bagre and Nechi, Colombia 1982 to 1986. Br J Dermatol 118 (1988) 737-744
8. Morini J.P., Jomaa B., Gorgi Y., Saguem M.H., Nouira R., Roujeau J.C., et al. Pemphigus foliaceus in young women. An endemic focus in the Sousse area of Tunisia. Arch Dermatol 129 (1993) 69-73
9. Diaz L., Sampaio S., Rivitti E., Martins C., Cunha P., Lombardi C., et al. Endemic pemphigus foliaceus (fogo selvagem). I. Clinical features and immunopathology. J Am Acad Dermatol 20 (1989) 657-669
10. Emery D.J., Diaz L.A., Fairley J.A., López A., Taylor A.F., and Giudice G.J. Pemphigus foliaceus and pemphigus vulgaris autoantibodies react with the extracellular domain of desmoglein-1. J Invest Dermatol 104 (1995) 323-328
11. Futamura S., Martins C., Rivitti E.A., Labib R.S., Diaz L.A., and Anhalt G.J. Ultrastructural studies of acantholysis induced in vivo by passive transfer of IgG from endemic pemphigus foliaceus (Fogo Selvagem). J Invest Dermatol 93 (1989) 480-485
12. Hans-Filho G., dos Santos V., Katayama J.H., Aoki V., Rivitti E.A., Sampaio S.A., et al. An active focus of high prevalence of fogo selvagem on an Amerindian reservation in Brazil. Cooperative Group on Fogo Selvagem Research. J Invest Dermatol 107 (1996) 68-75
13. Qian Y, Qaqish BF, Andraca E, Flores G, Aoki V, Hans-Filho G, et al. IgE anti-desmoglein 1 autoantibodies and its implication on the etiology of endemic pemphigus foliaceus. 2009 (Submitted).
14. Abbas A.K., Lichtman A.H., and Pober J.S. B cell activation and antibody production. Cellular and molecular immunology. 5th Ed-Updated (2005), Elsevier Saunders, Philadelphia, PA p. 190-1
15. Hamkar R., Jalilvand S., Mokhtari-Azad T., Nouri Jelyani K., Dahi-Far H., Soleimanjahi H., et al. Assessment of IgM enzyme immunoassay and IgG avidity assay for distinguishing between primary and secondary immune response to rubella vaccine. J Virol Methods 130 (2005) 59-65
16. Obel N., Hoier-Madsen M., and Kangro H. Serological and clinical findings in patients with serological evidence of reactivated Epstein-Barr virus infection. APMIS 104 (1996) 424-428
17. Chu C.M. Immunoglobulin class M anti-hepatitis B core antigen for serodiagnosis of acute hepatitis: pitfalls and recommendations. J Gastroenterol Hepatol 21 (2006) 789-791
18. Cermakova Z., Ryskova O., Honegr K., Cermakova E., and Hanovcova I. Diagnosis of Lyme borreliosis using enzyme immunoanalysis. Med Sci Monit 11 (2005) BR121-BR125
19. Montoya J.G. Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J Infect Dis 185 Suppl 1 (2002) S73-S82
20. Reis M.M., Tessaro M.M., and D'Azevedo P.A. Toxoplasma-IgM and IgG-avidity in single samples from areas with a high infection rate can determine the risk of mother-to-child transmission. Rev Inst Med Trop Sao Paulo 48 (2006) 93-98
21. Diaz L.A., Prisayanh P.S., Dasher D.A., Li N., Evangelista F., Aoki V., et al. The IgM anti-desmoglein 1 response distinguishes Brazilian pemphigus foliaceus (fogo selvagem) from other forms of pemphigus. J Invest Dermatol 128 (2008) 667-675
22. Manson J.J., Mauri C., and Ehrenstein M.R. Natural serum IgM maintains immunological homeostasis and prevents autoimmunity. Springer Semin Immunopathol 26 (2005) 425-432
23. Coutinho A., Kazatchkine M.D., and Avrameas S. Natural autoantibodies. Curr Opin Immunol 7 (1995) 812-818
24. Mouthon L., Lacroix-Desmazes S., Nobrega A., Barreau C., Coutinho A., and Kazatchkine M.D. The self-reactive antibody repertoire of normal human serum IgM is acquired in early childhood and remains conserved throughout life. Scand J Immunol 44 (1996) 243-251
25. Ferreira R., Barreto M., Santos E., Pereira C., Martins B., Andreia R., et al. Heritable factors shape natural human IgM reactivity to Ro60/SS-A and may predispose for SLE-associated IgG anti-Ro and anti-La autoantibody production. J Autoimmun 25 (2005) 155-163
26. Forger F., Matthias T., Oppermann M., Becker H., and Helmke K. Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis. Lupus 13 (2004) 36-44
27. Li Q.Z., Xie C., Wu T., Mackay M., Aranow C., Putterman C., et al. Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. J Clin Invest 115 (2005) 3428-3439
28. Stahl D., Hoemberg M., Cassens U., Pachmann U., and Sibrowski W. Evidence that human autoimmune thrombocytopenia mediated by both immunoglobulin isotypes IgM and IgG is an independent disease entity. Eur J Haematol 75 (2005) 318-327
29. Stahl D., and Sibrowski W. Warm autoimmune hemolytic anemia is an IgM-IgG immune complex disease. J Autoimmun 25 (2005) 272-282
30. Moraes M., Fernández-Vina M., Lázaro A., Diaz Filho L., Friedman H., Rivitti E., et al. An epitope in the third hypervariable region of the DRB1 gene is involved in the susceptibility to endemic pemphigus foliaceus (fogo selvagem) in three different Brazilian populations. Tissue Antigens 49 (1997) 35-40
31. Bhol K., Natarajan K., Nagarwalla N., Mohimen A., Aoki V., and Ahmed A. Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity. Proc Natl Acad Sci USA 92 (1995) 5239-5243
32. Brooks W., Lee Y., Abell E., and Deng J. Comparison of IgG subclasses and complement binding activity of autoantibodies from patients with bullous pemphigoid and pemphigus. J Clin Lab Anal 3 (1989) 307-311
33. David M., Katzenelson V., Hazaz B., Ben-Chetrit A., and Sandbank M. Determination of IgG subclasses in patients with pemphigus with active disease and in remission. Arch Dermatol 125 (1989) 787-790
34. Jones C.C., Hamilton R.G., and Jordon R.E. Subclass distribution of human IgG autoantibodies in pemphigus. J Clin Immunol 8 (1988) 43-49
35. Parlowsky T., Welzel J., Amagai M., Zillikens D., and Wygold T. Neonatal pemphigus vulgaris: IgG4 autoantibodies to desmoglein 3 induce skin blisters in newborns. J Am Acad Dermatol 48 (2003) 623-625
36. Hacker M.K., Janson M., Fairley J.A., and Lin M.S. Isotypes and antigenic profiles of pemphigus foliaceus and pemphigus vulgaris autoantibodies. Clin Immunol 105 (2002) 64-74
37. Torzecka J.D., Wozniak K., Kowalewski C., Waszczykowska E., Sysa-Jedrzejowska A., Pas H.H., et al. Circulating pemphigus autoantibodies in healthy relatives of pemphigus patients: coincidental phenomenon with a risk of disease development?. Arch Dermatol Res 299 (2007) 239-243
38. Yamada H., Hashimoto T., and Nishikawa T. IgG Subclasses of intercellular and basement membrane zone antibodies: the relationship to the capability of complement fixation. J Invest Dermatol 92 (1989) 585-587
39. Yeh S.W., Cavacini L.A., Bhol K.C., Lin M.S., Kumar M., Duval M., et al. Pathogenic human monoclonal antibody against desmoglein 3. Clin Immunol 120 (2006) 68-75
40. Rock B., Martins C.R., Theofilopoulos A.N., Balderas R.S., Anhalt G.J., Labib R.S., et al. The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem). N Engl J Med 320 (1989) 1463-1469
41. Allen E.M., Giudice G.J., and Diaz L.A. Subclass reactivity of pemphigus foliaceus autoantibodies with recombinant human desmoglein. J Invest Dermatol 100 (1993) 685-691
42. Marques Babosa Dos Santos S., Lima Filgueira A., Andrade Patrus O., and Diaz L. Perfil evolutivo das subclasses de imunoglobulinas gama em pacientes de pênfigo foliáceo endêmico. An Bras Dermatol 76 (2001) 561-574
43. Hacker-Foegen M.K., Janson M., Amagai M., Fairley J.A., and Lin M.S. Pathogenicity and epitope characteristics of anti-desmoglein- 1 from pemphigus foliaceus patients expressing only IgG1 autoantibodies. J Invest Dermatol 121 (2003) 1373-1378
44. Aoki V., Huang M.H., Perigo A.M., Fukumori L.M., Maruta C.W., Santi C.G., et al. Endemic pemphigus foliaceus (fogo selvagem) and pemphigus vulgaris: immunoglobulin G heterogeneity detected by indirect immunofluorescence. Rev Hosp Clin Fac Med Sao Paulo 59 (2004) 251-256
45. Rock B., Labib R., and Diaz L. Monovalent Fab'immunoglobulin fragments from endemic pemphigus foliaceus autoantibodies reproduce the human disease in neonatal Balb/c mice. J Clin Invest 85 (1990) 296-299
46. Calvanico N., Swartz S., and Diaz L. Affinity immunoblotting studies on the restriction of autoantibodies from endemic pemphigus foliaceus patients. J Autoimmun 6 (1993) 145-157
47. Qaqish B.F., Prisayanh P., Qian Y., Andraca E., Li N., Aoki V., et al. Development of an IgG4-based predictor of endemic pemphigus foliaceus (fogo selvagem). J Invest Dermatol 129 (2009) 110-118
48. Warren S.J., Lin M.S., Giudice G.J., Hoffmann R.G., Hans-Filho G., Aoki V., et al. The prevalence of antibodies against desmoglein 1 in endemic pemphigus foliaceus in Brazil. Cooperative Group on Fogo Selvagem Research. N Engl J Med 343 (2000) 23-30
49. Li N., Aoki V., Hans-Filho G., Rivitti E.A., and Diaz L.A. The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem). J Exp Med 197 (2003) 1501-1510
50. Warren S., Arteaga L., Rivitti E., Aoki V., Hans-Filho G., Qaqish B., et al. The role of subclass switching in the pathogenesis of endemic pemphigus foliaceus. J Invest Dermatol 120 (2003) 104-108
51. Qian Y, Clarke SH, Aoki V, Hans-Filhio G, Rivitti EA, Diaz LA. Antigen selection of anti-DSG1 autoantibodies during and before the onset of endemic pemphigus foliaceus. J Invest Dermatol. 2009 (In press).
52. Kalantarov G.F., Rudchenko S.A., Lobel L., and Trakht I. Development of a fusion partner cell line for efficient production of human monoclonal antibodies from peripheral blood lymphocytes. Hum Antibodies 11 (2002) 85-96
53. Aranha Campos J. Penfigo foliaceo (Fogo Selvagem). Aspectos clinicos e epidemiologicos. Comp Melhoramentos S Paulo; 1942.
54. Auad A. Penfigo foliaceo Sul-Americano no Estado de Goias. Rev Patol Trop 1 (1972) 293-346
55. Minelli L. Geografia Medica do Penfigo Foliaceo Sul Americano no Estado do Parana. An Bras Dermatol Sifilol 51 (1976) 173-181
56. Vieira J. Pemphigus Foliaceus (Fogo Selvagem). An endemic disease of the state of Sao Paulo (Brazil). Arch Dermatol 41 (1940) 858-863
57. Dias J., and Schofield C. The evolution of Chagas disease (American trypanosomiasis) control after 90 years since Carlos Chagas discovery. Mem Inst Oswaldo Cruz 94 Suppl 1 (1999) 103-121
58. Kirchhoff L.V. American trypanosomiasis (Chagas' disease)-a tropical disease now in the United States. N Engl J Med 329 (1993) 639-644
59. Williams-Blangero S., VandeBerg J.L., and Teixeira A.R. Attitudes towards Chagas' disease in an endemic Brazilian community. Cad Saude Publica 15 (1999) 7-13
60. Goihman-Yahr M. American mucocutaneous leishmaniasis. Dermatol Clin 12 (1994) 703-712
61. Klaus S., and Frankenburg S. Cutaneous leishmaniasis in the Middle East. Clin Dermatol 17 (1999) 137-141
62. Medeiros A.C.R., and Roselino A.M.F. Leishmaniose tegumentar americana: do histórico aos dias de hoje / Cutaneous american leishmaniasis: from the beginning until nowadays. An Bras Dermatol 74 (1999) 329-336
63. Molyneux D.H., and Morel C. Onchocerciasis and Chagas' disease control: the evolution of control via applied research through changing development scenarios. Br Med Bull 54 (1998) 327-339
64. Routh H.B., and Bhowmik K.R. Filariasis. Dermatol Clin 12 (1994) 719-727
65. Paes-Leme C. Contribuicao ao estudo do Tokelau. Rio de Janeiro, Brazil: Tese Facultade de Medicina do Rio de Janeiro; 1903.
66. Cunha PR. Sero Epidemiologia do Fogo Selvagem em um Foco Endemico Remanescente do Estado de Sao Paulo. [Tese de Docencia]. Sao Paulo, Brazil: Facultade de Medicina da Universidade de Sao Paulo; 1987.
67. Da Silva LJ. A Agricultura Paulista a Partir de 1950. In: Anexo 3: A Evolucion da Doenca de Chagas no Estado de Sao Paulo. Sao Paulo: Funcraf-Hucite C Publisher; 1999.
68. Empinotti J., Diaz L., Martins C., Rivitti E., Sampaio S., Lombardi C., et al. Endemic pemphigus foliaceus in western Parana, Brazil (1976-1988). Cooperative Group for Fogo Selvagem Research. Br J Dermatol 123 (1990) 431-437
69. Empinotti J.C., Aoki V., Filgueira A., Sampaio S.A., Rivitti E.A., Sanches Jr. J.A., et al. Clinical and serological follow-up studies of endemic pemphigus foliaceus (fogo selvagem) in Western Parana, Brazil (2001-2002). Br J Dermatol 155 (2006) 446-450
70. Proenca N.G. Declinio do Penfigo Foliaceo no Estado de Sao Paulo. Rev Paulista Med (Brasil) 89 (1977) 97-100
71. Silveira A., and Vinhaes M. Elimination of vector-borne transmission of Chagas disease. Mem Inst Oswaldo Cruz 94 Suppl 1 (1999) 405-411
72. Vinhaes M.C., and Dias J.C. Chagas disease in Brazil. Cad Saude Publica 16 Suppl 2 (2000) 7-12
73. Eaton D.P., Diaz L.A., Hans-Filho G., Santos V.D., Aoki V., Friedman H., et al. Comparison of black fly species (Diptera: Simuliidae) on an Amerindian reservation with a high prevalence of fogo selvagem to neighboring disease-free sites in the State of Mato Grosso do Sul, Brazil. The Cooperative Group on Fogo Selvagem Research. J Med Entomol 35 (1998) 120-131
74. Aoki V., Millikan R.C., Rivitti E.A., Hans-Filho G., Eaton D.P., Warren S.J., et al. Environmental risk factors in endemic pemphigus foliaceus (fogo selvagem). J Investig Dermatol Symp Proc 9 (2004) 34-40
75. Hilario-Vargas J., Dasher D.A., Li N., Aoki V., Hans-Filho G., dos Santos V., et al. Prevalence of anti-desmoglein-3 antibodies in endemic regions of Fogo selvagem in Brazil. J Invest Dermatol 126 (2006) 2044-2048
76. Ribeiro J.M. Blood-feeding arthropods: live syringes or invertebrate pharmacologists?. Infect Agents Dis 4 (1995) 143-152
77. Billingsley P.F., Baird J., Mitchell J.A., and Drakeley C. Immune interactions between mosquitoes and their hosts. Parasite Immunol 28 (2006) 143-153
78. Champagne D.E., Wasserman H.A., Kumar S., and Singh S. Pharmacological and immunological properties of saliva of the blood-feeding insects Rhodnius prolixus and Aedes aegypti. Physiological Entomology 29 (2004) 269-277
79. Gillespie R.D., Mbow M.L., and Titus R.G. The immunomodulatory factors of bloodfeeding arthropod saliva. Parasite Immunol 22 (2000) 319-331
80. Theodos C.M., Ribeiro J.M., and Titus R.G. Analysis of enhancing effect of sand fly saliva on Leishmania infection in mice. Infect Immun 59 (1991) 1592-1598
81. Manso E.C., Morato-Castro F.F., Yee C.J., Croce M., Palma M.S., and Croce J. Honeybee venom specific IgG subclass antibodies in Brazilian beekeepers and in patients allergic to bee stings. J Investig Allergol Clin Immunol 8 (1998) 46-51
82. Valenzuela J.G., Belkaid Y., Garfield M.K., Mendez S., Kamhawi S., Rowton E.D., et al. Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein. J Exp Med 194 (2001) 331-342
83. Kurniawan A., Yazdanbakhsh M., van Ree R., Aalberse R., Selkirk M.E., Partono F., et al. Differential expression of IgE and IgG4 specific antibody responses in asymptomatic and chronic human filariasis. J Immunol 150 (1993) 3941-3950
84. Roselino A., Figueredo J., Kounga K., Reddy V., and Lerner E. Serum IgG from pemphigus foliaceus patients reacts against maxadilan. J Invest Dermatol 117 (2001) 460
85. Arca B., Lombardo F., Valenzuela J.G., Francischetti I.M., Marinotti O., Coluzzi M., et al. An updated catalogue of salivary gland transcripts in the adult female mosquito, Anopheles gambiae. J Exp Biol 208 (2005) 3971-3986
86. Champagne D.E., Nussenzveig R.H., and Ribeiro J.M. Purification, partial characterization, and cloning of nitric oxide-carrying heme proteins (nitrophorins) from salivary glands of the blood-sucking insect Rhodnius prolixus. J Biol Chem 270 (1995) 8691-8695
87. Charlab R., Valenzuela J.G., Rowton E.D., and Ribeiro J.M. Toward an understanding of the biochemical and pharmacological complexity of the saliva of a hematophagous sand fly Lutzomyia longipalpis. Proc Natl Acad Sci U S A 96 (1999) 15155-15160
88. Valenzuela J.G., Belkaid Y., Rowton E., and Ribeiro J.M. The salivary apyrase of the blood-sucking sand fly Phlebotomus papatasi belongs to the novel Cimex family of apyrases. J Exp Biol 204 (2001) 229-237
89. Valenzuela J.G., Garfield M., Rowton E.D., and Pham V.M. Identification of the most abundant secreted proteins from the salivary glands of the sand fly Lutzomyia longipalpis, vector of Leishmania chagasi. J Exp Biol 207 (2004) 3717-3729
90. Hemmer W., Focke M., Kolarich D., Dalik I., Gotz M., and Jarisch R. Identification by immunoblot of venom glycoproteins displaying immunoglobulin E-binding N-glycans as cross-reactive allergens in honeybee and yellow jacket venom. Clin Exp Allergy 34 (2004) 460-469
91. Volf P., Tesarova P., and Nohynkova E.N. Salivary proteins and glycoproteins in phlebotomine sandflies of various species, sex and age. Med Vet Entomol 14 (2000) 251-256
92. Hill E., Broadbent I.D., Chothia C., and Pettitt J. Cadherin superfamily proteins in Caenorhabditis elegans and Drosophila melanogaster. J Mol Biol 305 (2001) 1011-1024
93. Barrett D.J., and Ayoub E.M. IgG2 subclass restriction of antibody to pneumococcal polysaccharides. Clin Exp Immunol 63 (1986) 127-134
94. Vos Q., Lees A., Wu Z.Q., Snapper C.M., and Mond J.J. B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol Rev 176 (2000) 154-170
95. Cobb B.A., and Kasper D.L. Coming of age: carbohydrates and immunity. Eur J Immunol 35 (2005) 352-356
96. Nedelec J., Boucraut J., Garnier J.M., Bernard D., and Rougon G. Evidence for autoimmune antibodies directed against embryonic neural cell adhesion molecules (N-CAM) in patients with group B meningitis. J Neuroimmunol 29 (1990) 49-56